eMedicine Specialties > Emergency Medicine > Allergy & Immunology

Angioedema

Author: Nedra R Dodds, MD, Medical Director, Opulence Aesthetic Medicine
Coauthor(s): Richard Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Contributor Information and Disclosures

Updated: Oct 20, 2008

Introduction

Background

Angioedema and urticaria should be viewed as varying manifestations of the same pathologic process. Postcapillary venule inflammation results in fluid leakage and edema in both conditions. However, angioedema involves vessels in the layers of the skin below the dermis, while urticaria is localized superficial to the dermis. This results in varying clinical presentations.

The subdermal source of angioedema results in well-demarcated, localized, nonpitting edema. Urticaria is localized to the superficial portion of the dermis and is characterized by well-circumscribed wheals with raised erythematous borders and central blanching. These often coalesce to become giant wheals.

These conditions can occur together or separately. Recurrent episodes of one or both conditions for less than a 6-week duration are considered acute, whereas longer-lasting attacks are considered chronic.

Angioedema, with or without urticaria, is classified as allergic, hereditary, or idiopathic. Complications range from dysphonia or dysphagia to respiratory distress, complete airway obstruction, and death.

Pathophysiology

Angioedema involves vascular leakage beneath the dermis and subcutis. This response is mediated by vasoactive mediators, such as histamine, serotonin, and kinins (eg, bradykinins), which cause the arterioles to dilate while inducing a brief episode of vascular leakage in the venules, where the junction between the endothelial cells appears looser than in the capillaries and arterioles.

Frequency

United States

Approximately 15% of the general population is affected by recurrent idiopathic episodes. The most common kind does not have a discoverable cause.

Mortality/Morbidity

Morbidity and mortality are directly related to the severity of airway obstruction.

Race

No specific racial predilection exists.

Sex

Women tend to have more occurrences than men.

Age

Persons who are predisposed have an increase in frequency of attacks after adolescence, with the peak incidence occurring in the third decade of life.

Clinical

History

  • General history
    • Urticarial eruptions usually appear at intervals and are intensely pruritic.
    • Patients with angioedema or urticaria should be questioned in detail to identify the offending antigen (in cases of allergic angioedema).
    • Any family history or history of recurrent episodes with the use of particular agents must be sought.
  • Drugs associated with urticaria and angioedema include the following:
    • Radiocontrast agents
    • Opiates
    • Dextran
    • Angiotensin-converting enzyme (ACE) inhibitors
    • Aspirin
    • Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Common sources of antigens that cause urticaria and angioedema include the following:
    • Hymenoptera envenomations
    • Food allergies such as fresh berries, shellfish, fish, nuts, tomatoes, eggs, milk, chocolate, food additives, and preservatives
    • Local trauma (eg, dental procedure, tonsillectomy)
    • Exposure to water, sunlight, cold, or heat
    • Animal dander (from scales of shed skin)
    • Emotional stress
    • Post infection or illness, including autoimmune disorders such as thyroid autoimmunity and leukemia
  • Chronic urticaria (increasingly associated with Helicobacter pylori bacteria)

Physical

  • General examinations
    • Patients usually present with the acute onset of well-demarcated cutaneous edema of distensible tissues (eg, lips, eyes, earlobes, tongue, uvula).
    • The face, extremities, and genitalia are most commonly affected.
  • Airway assessment
    • First, determine airway patency.
    • Severe attacks can herald the onset of systemic anaphylaxis, characterized initially by dyspnea.
  • Gastrointestinal (GI): Massive edema of the subcutaneous tissue in the abdominal region may present with abdominal distention and signs consistent with bowel obstruction.

Causes

  • Immunoglobulin E (IgE)-mediated angioedema/urticaria may result from antigen ingestion (eg, food, drug) or from parenteral exposure (eg, medications, Hymenoptera).
  • Complement-mediated angioedema/urticaria:
    • This angioedema involves immune complex–mediated necrotizing cutaneous venulitis manifested as serum sickness.
    • It is characterized by fever, angioedema, arthralgias, urticaria, and palpable purpura.
  • Hereditary angioedema
    • This type of angioedema is characterized by recurrent self-limited attacks involving the skin, subcutaneous tissue, upper respiratory tract, or GI tract. Attacks may last from several hours to 2-3 days.
    • GI or upper respiratory tract attacks may be precipitated by local trauma (eg, dental procedures, tonsillectomy).
  • Idiopathic angioedema appears to manifest due to direct mast cell–releasing agents in certain compounds (eg, radiocontrast media, opiates, dextran).
    • Other drugs may precipitate attacks by effects on arachidonic acid metabolism (eg, aspirin, NSAIDs, any compounds that are cyclooxygenase inhibitors).
    • ACE inhibitors precipitate attacks by directly interfering with the degradation of bradykinin, thereby potentiating its biological effect.

More on Angioedema

Overview: Angioedema
Differential Diagnoses & Workup: Angioedema
Treatment & Medication: Angioedema
Follow-up: Angioedema
References

References

  1. Blumen IJ, Rodenberg H, eds. Principles of Medicine. 2nd ed. 1994.

  2. Cooper KD. Urticaria and angioedema: diagnosis and evaluation. J Am Acad Dermatol. Jul 1991;25(1 Pt 2):166-74; discussion 174-6. [Medline].

  3. Gavras I, Gavras H. Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers?. Arch Intern Med. Jan 27 2003;163(2):240-1. [Medline].

  4. Horan RF, Schneider LC, Sheffer AL. Allergic skin disorders and mastocytosis. JAMA. Nov 25 1992;268(20):2858-68. [Medline].

  5. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. Sep 2005;53(3):373-88; quiz 389-92. [Medline].

  6. Lewiston NJ. Bronchiectasis. In: Hillman, BC, ed. Pediatric Respiratory Disease. Philadelphia: WB Saunders; 1993:222-229.

  7. Price KS, Thomson DM. Localized unilateral periorbital edema induced by aspirin. Ann Allergy Asthma Immunol. Nov 1997;79(5):420-2. [Medline].

  8. Salomone J. Anaphylaxis and acute allergic reactions. In: Tintinalli JE, Keleg GD, eds. Emergency Medicine: A Comprehensive Study Guide. New York: McGraw-Hill; 1996:209-211.

  9. Sheehan C. Clinical Immunology: Principles of Laboratory and Diagnosis. Philadelphia: Lippincott-Raven Publishers; 1997:43-44, 140, 313.

  10. Stern M. Hereditary Angioedema Association. April 2001.

Further Reading

Keywords

anaphylaxis, allergies, allergic reaction, urticaria, edema, tongue swelling, angioneurotic edema, atrophedema, Bannister disease, Bannister's disease, circumscribed edema, giant hives, giant urticaria, urticaria gigans, urticaria gigantea, Milton disease, Milton's disease, periodic edema, Quincke disease, Quincke's disease, Quincke edema, Quincke's edema, urticaria tuberosa, dysphonia, dysphagia, respiratory distress, complete airway obstruction, giant wheals, allergic angioedema, idiopathic angioedema, urticarial eruptions, hymenoptera envenomations, food allergies, chronic urticaria, emotional stress, Helicobacter pylori, thyroid autoimmunity, leukemia, arthralgias, palpable purpura

Contributor Information and Disclosures

Author

Nedra R Dodds, MD, Medical Director, Opulence Aesthetic Medicine
Nedra R Dodds, MD is a member of the following medical societies: American Academy of Anti-Aging Medicine, American Academy of Cosmetic Surgery, American College of Emergency Physicians, American Medical Association, National Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Richard Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center
Richard Sinert, DO is a member of the following medical societies: American College of Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Edward Bessman, MD, Chairman, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University
Edward Bessman, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Matthew M Rice, MD, JD, FACEP, Senior Vice President, Chief Medical Officer, Northwest Emergency Physicians; Assistant Clinical Professor of Medicine, University of Washington at Seattle
Matthew M Rice, MD, JD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Washington State Medical Association
Disclosure: Team Health  Salary Employment

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School
Jonathan Adler, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: eMedicine.com, Inc. Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.